← All stocks

Cadrenal Therapeutics, Inc.

CVKD Net buying
CIK 0001937993 #5392 in the set updated 17 Sep 2026
Bought (120 mo)
$161.40K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.10M
$1.03M on a plan · $0.00 straight out of an exercise
Sold at will
$70.35K
3 of 45 sales
Net
−$936.70K
+$91.05K against sales at will

By person

4 insiders · 56 transactions
0.3×

Quang X. Pham holds only 0.3 times base salary in stock. $298.72K of shares against $751.28K in salary for 2025.

Salary from the company's own proxy. The shares are what Quang X. Pham last reported holding, valued at $3.03, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pham Quang X
Chairman and CEO
$100.13K (7)
$700.65K (33) scheduled
−$600.51K
98,589
$298.72K
−54.8%
Szot Matthew K
Chief Financial Officer
$397.46K (12) scheduled
−$397.46K
0
$0.00
MURPHY JOHN RAYMOND
Director
$61.27K (4)
+$61.27K
614,792
$1.86M
+1,130%
WILSON GLYNN
Director
50,000
$151.50K

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 1,658,771 to 3,567,592 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
MURPHY JOHN RAYMOND
5 Oct 2023
Director
Buy
2,669
$0.69
$1.84K
MURPHY JOHN RAYMOND
4 Oct 2023
Director
Buy
17,331
$0.70
$12.13K
Pham Quang X
5 Sep 2023
CEO and Chairman
Buy
20,000
$0.90
$17.99K
Pham Quang X
5 Sep 2023
CEO and Chairman
Buy
20,000
$0.91
$18.20K
Pham Quang X
1 Sep 2023
CEO and Chairman
Buy
10,000
$0.84
$8.43K
Pham Quang X
1 Sep 2023
CEO and Chairman
Buy
10,000
$0.92
$9.17K
Pham Quang X
1 Sep 2023
CEO and Chairman
Buy
20,000
$0.92
$18.44K
Pham Quang X
1 Sep 2023
CEO and Chairman
Buy
20,000
$0.93
$18.58K
Pham Quang X
1 Sep 2023
CEO and Chairman
Buy
10,000
$0.93
$9.32K
MURPHY JOHN RAYMOND
21 Mar 2023
Director
Buy
10,000
$1.39
$13.90K
MURPHY JOHN RAYMOND
16 Mar 2023
Director
Buy
20,000
$1.67
$33.40K

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 42
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 774,792
History held since 24 Jan 2023